REVIEW article
Front. Immunol.
Sec. Molecular Innate Immunity
Bitter Taste Receptors in the Gut-Vascular Axis: A 1 Novel Target for Immune and Metabolic Regulation 2 of Hypertension
Provisionally accepted- 1Tianjin University of Traditional Chinese Medicine, Tianjin, China
- 2The Sixth Medical Center of PLA General Hospital, 100048 Beijing, China, Beijing, China
- 3The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China., Tianjin, China
- 4Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Hypertension affects approximately 1.3 billion adults worldwide, yet the control rate remains 25 below 20%, highlighting the limitation of current therapies that primarily lower blood pressure 26 without targeting the underlying pathophysiological mechanisms. Recent research indicates that 27 bitter taste receptors, which are structurally distinct members of the G protein-coupled receptor 28 superfamily, have functions that extend beyond their traditional role in oral taste perception. These 29 receptors are extensively expressed along the gut-vascular axis, including in vascular smooth 30 muscle, cardiac tissue, macrophages, and gastrointestinal organs, thereby positioning them as 31 crucial nodes in the regulation of immunometabolic processes. This review systematically 32 elucidates the complex regulatory mechanisms of gut-vascular axis TAS2Rs in the 33 pathophysiology of hypertension and investigates TAS2R-targeting compounds, with particular 34 emphasis on their effects in modulating blood pressure. This review consolidates evidence on 35 TAS2R signaling across vascular, immune, and gastrointestinal interfaces to outline therapeutic 36 implications for hypertension.
Keywords: Gut-vascular axis, Hypertension, Immunometabolism, Macrophage polarization, Tas2Rs, therapeutic targets
Received: 28 Sep 2025; Accepted: 19 Dec 2025.
Copyright: © 2025 Wei, Lyu, Jia, Zhang, Zhang, Xu and Hua. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Min Zhang
Qiang Xu
Shengyu Hua
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
